Macintosh Versus Macgrath for Laryngoscopy in COVID 19 Hypoxemic ICU Patients

July 8, 2021 updated by: Mhamed Sami Mebazaa, Mongi Slim Hospital

In this comparative prospective study, we aim to compare the classic Macintosh laryngoscope and the Mac Grath videolaryncoscope in ICU covid 19 patients recruiting intubation and invasive mechanical ventilation.

patients meeting inclusion criteria were randomized in 2 groups: MacGrath and Macintosh.

we collected anthropometric and intubation data among all patients, and the 2 groups were compared regarding the time for intubation, the need of alternative techniques to intubate and the impact on the oxygenation by recording the lowest SPO2.

Study Overview

Status

Not yet recruiting

Detailed Description

In this comparative prospective study, we aim to compare the classic Macintosh laryngoscope and the Mac Grath videolaryncoscope in ICU covid 19 patients recruiting intubation and invasive mechanical ventilation.

All hypoxemic COVID19 patients requiring intubation were enrolled in this trial.

all patients had a preoxygenation with non invasive ventilation with 100% oxygen.

patients meeting inclusion criteria were randomized in 2 groups: MacGrath and Macintosh.

we collected anthropometric and intubation data among all patients, and the 2 groups were compared regarding the time for intubation, the need of alternative techniques to intubate and the impact on the oxygenation by recording the lowest SPO2.

Study Type

Observational

Enrollment (Anticipated)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

ICU covid 19 patients requiring tracheal intubation

Description

Inclusion Criteria:

  • All COVID 19 hypoxemic patients requiring tracheal intubation

Exclusion Criteria:

  • hypoxemic cardiac arrest before intubation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Mac Grath
Patients of this group were intubated using Mac Gath videolaryngoscope
Patients of this group were intubated using Mac Gath videolaryngoscope
Machintosh
Patients of this group were intubated using the classic Macintosh laryngscoscope
Patients of this group were intubated using the Macintosh Laryngoscope

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time for tracheal intubation
Time Frame: 10 minutes
Time from the blade pass the lips until the first breath was administred
10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

August 1, 2021

Primary Completion (ANTICIPATED)

December 31, 2021

Study Completion (ANTICIPATED)

January 31, 2022

Study Registration Dates

First Submitted

July 8, 2021

First Submitted That Met QC Criteria

July 8, 2021

First Posted (ACTUAL)

July 9, 2021

Study Record Updates

Last Update Posted (ACTUAL)

July 9, 2021

Last Update Submitted That Met QC Criteria

July 8, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COVID-19 Acute Respiratory Distress Syndrome

Clinical Trials on Mac Grath

3
Subscribe